新 聞 及 資 訊
|
| |
| US FDA issues warning letters to marketers of topical ibuprofen drug products (English only) |
| |
The U.S. Food and Drug Administration announced that the agency issued warning letters to eight companies marketing unlawful over-the-counter (OTC) topical drug products containing the pain reliever ibuprofen. The companies cannot continue to market their products without FDA approval. The names of the products and manufacturers that received warning letters are:
1. Emuprofen (Progressive Emu, Inc.)
2. BioEntopic 15% Ibuprofen Crème (BioCentric Laboratories, Inc.)
3. Ibunex Topical Ibuprofen (Core Products International, Inc.)
4. LoPain AF 15% Ibuprofen Crème (Geromatrix Health Products)
5. IB-RELIEF (MEKT LLC)
6. Profen HP (Ridge Medical Products)
7. IbuPRO-10 Plus (Meditrend, Inc. dba Progena Professional Formulations)
8. IBU-RELIEF 12 (Wonder Laboratories)
The relevant link for the news is:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm179689.htm
Situation in Hong Kong: The above products are not registered in HK.
Ends/Friday, August 21, 2009
Issued at HKT 14:00
|
| |
